Sirtex Renews Grant to Support Vanderbilt's RESIN Registry of Y-90 Microspheres to Treat Liver Tumors
April 18, 2018—Vanderbilt University in Nashville, Tennessee, recently announced that Sirtex Medical Inc. has renewed a grant awarded to Daniel B. Brown, MD, and his Vanderbilt Health colleagues, for a research program designed to treat patients with liver tumors that cannot be addressed with surgery. The research agreement renewal from Sirtex will provide $2.64 million over 3 years to support a patient registry. Combined with the original contract, reimbursement to Vanderbilt totals more than $3 million.
